Welcome to LookChem.com Sign In|Join Free
  • or
(2S,5S)-trans-5-(4-fluorophenoxymethyl)-5-(4-N,O-bis-(phenoxycarbonyl)hydroxylamino-3-butyn-4-yl)tetrahydrofuran is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

175212-45-0

Post Buying Request

175212-45-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

175212-45-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 175212-45-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,1 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 175212-45:
(8*1)+(7*7)+(6*5)+(5*2)+(4*1)+(3*2)+(2*4)+(1*5)=120
120 % 10 = 0
So 175212-45-0 is a valid CAS Registry Number.

175212-45-0Downstream Products

175212-45-0Relevant academic research and scientific papers

Anomeric oxygen to carbon rearrangements of alkynyl tributylstannane derivatives of furanyl (γ)- and pyranyl (δ)-lactols

Buffet, Marianne F.,Dixon, Darren J.,Ley, Steven V.,Reynolds, Dominic J.,Storer, R. Ian

, p. 1145 - 1154 (2007/10/03)

Tetrahydropyran and tetrahydrofuran containing natural products, drugs and agrochemicals often possess carbon-carbon bonds adjacent to the heteroatom. Consequently, new methods for the construction of anomeric carbon-carbon bonds are of considerable importance. We have devised a new strategy to access these systems that requires the treatment of O-glycoside alkynyl tributylstannane derivatives of furanyl and pyranyl lactols with Lewis acid to effect oxygen to carbon rearrangements. This leads to the formation of the corresponding carbon linked alkynol products that can be further manipulated to produce key structural motifs and building blocks for the assembly of complex molecules.

A novel and simple asymmetric synthesis of CMI-977 (LDP-977): A potent anti-asthmatic drug lead

Gurjar, Mukund K.,Murugaiah,Radhakrishna,Ramana,Chorghade, Mukund S.

, p. 1363 - 1370 (2007/10/03)

A practical gram scale asymmetric synthesis of CMI-977 is described. A tandem double elimination of an α-chlorooxirane and concomitant intramolecular nucleophilic substitution was used as the key step. Jacobsen hydrolytic kinetic resolution and Sharpless

A short and efficient stereoselective synthesis of the potent 5-lipoxygenase inhibitor, CMI-977

Dixon,Ley,Reynolds,Chorghade

, p. 1043 - 1053 (2007/10/03)

A short and efficient synthesis of the potent 5-lipoxygenase inhibitor CMI-977 has been accomplished, utilising an oxygen to carbon rearrangement of an anomerically linked alkynyl stannane tetrahydrofuranyl ether derivative as the key step.

A short and efficient stereoselective synthesis of the potent 5- lipoxygenase inhibitor CMI-977

Dixon, Darren J.,Ley, Steven V.,Reynolds, Dominic J.,Chorghade, Mukund S.

, p. 1955 - 1961 (2007/10/03)

A short and efficient synthesis of the potent 5-lipoxygenase inhibitor CMI-977 is described using as the key step a stereoselective anomeric oxygen to carbon rearrangement of an alkynyl stannane tetrahydrofuranyl ether derivative mediated by boron trifluoride etherate.

A versatile approach to anti-asthmatic compound CMI-977 and its six- membered analogue

Gurjar, Mukund K.,Krishna, L. Murali,Reddy, B. Sridhar,Chorghade, Mukund S.

, p. 557 - 560 (2007/10/03)

The synthesis of the anti-asthmatic compound CMI-977 is described. The tetrahydrofuran ring was effectively constructed by involving olefin metathesis while the stereoselective introduction of the 1-N- hydroxyureidylbut-3-yn-4-yl side-chain was achieved b

Synthesis of CMI-977, a potent 5-lipoxygenase inhibitor

Cai, Xiong,Chorghade, Mukund S.,Fura, Aberra,Grewal, Gurmit S.,Jauregui, Karen A.,Lounsbury, Heather A.,Scannell, Ralph T.,Yeh, C. Grace,Young, Michelle A.,Yu, Shaoxia,Guo, Liang,Moriarty, Robert M.,Penmasta, Raju,Rao, Munagala S.,Singhal, Rajesh K.,Song, Zhengzhe,Staszewski, James P.,Tuladhar, Sudersan M.,Yang, Sanmin

, p. 73 - 76 (2013/09/08)

CMI-977 is a potent 5-lipoxygenase inhibitor that intervenes in the production of leukotrienes and is presently being developed for the treatment of chronic asthma. It is a single enantiomer with an all-trans (2S,5S) configuration. Of the four isomers of CMI-977, the S,S isomer was found to have the best biological activity and was selected for further development. The enantiomerically pure product was synthesized on a 2-kg scale from (S)-(+)-hydroxymethyl-γ-butyrolactone.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 175212-45-0